|
|
|
|
 |
|
SENSEX
|
 |
78.65
|
0.31%
|
|
25806.20
|
|
|
|
NIFTY
|
 |
118.75
|
0.14%
|
|
83857.88
|
|
|
|
Nasdaq
|
 |
-336.92
|
-1.43%
|
|
23255.19
|
|
|
|
Nikkei 225
|
 |
2065.48
|
3.92%
|
|
54720.66
|
|
|
|
FTSE 100
|
 |
-27.00
|
-0.26%
|
|
10314.60
|
|
|
 |
|
|
|
|
|
|
|
|
YOU ARE ON
Equity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Industry : Pharmaceuticals & Drugs |
House : Cipla |
|
BSE Code |
500087
|
|
ISIN Demat |
INE059A01026
|
|
Book Value (Rs) |
419.19
|
|
|
NSE Code |
CIPLA
|
|
Dividend Yield % |
1.20
|
|
Market Cap (Rs) |
1073540.52
|
|
|
TTM PE(x) |
23.26
|
|
TTM EPS(Rs) |
57.14
|
|
Face Value(Rs.) |
2
|
|
|
|
|
|
|
|
|
|
|
|
Incorporation Year
|
17-08 1935
|
|
Registered Office
|
Cipla House, Peninsula Business Park,Ganpatrao Kadam Marg,Lower Parel, Mumbai, Maharashtra-400013 .
|
|
ISINNO
|
INE059A01026
|
|
Phone
|
022-24826000
|
|
E-mail
|
contactus@cipla.com |
|
URL
|
www.cipla.com |
|
Industry
|
Pharmaceuticals & Drugs
|
|
Chairman
|
Y K Hamied
|
|
Managing Director
|
Umang Vohra
|
|
Company Secretary
|
Rajendra Chopra
|
|
Listing
|
BSE,NSE,Luxembourg
|
|
|
|
|
|
|
|
|
|
|
|